Response to commentary: "Re-evaluation of the Big Blue® mouse assay of propiconazole suggests lack of mutagenicity"

Environmental and Molecular Mutagenesis

Volumn 53, Issue 7, 2012, Pages 574-577

  Ross, Jeffrey A ^a   Leavitt, Sharon A ^a  

^a U S ENVIRONMENTAL PROTECTION AGENCY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DINUCLEOTIDE; MYCLOBUTANIL; PROPICONAZOLE; TRIADIMEFON;

ASSAY; DNA SEQUENCE; EVALUATION; GENOTOXICITY; LETTER; MOUSE; MUTAGENESIS; MUTAGENICITY; MUTATION; NONHUMAN; PHENOTYPE; QUALITY CONTROL; SENSITIVITY ANALYSIS; SEQUENCE ANALYSIS; TRANSGENIC MOUSE;

ANIMALS; MALE; MUTAGENICITY TESTS; MUTAGENS; MUTATION; TRIAZOLES;

EID: 84864835873     PISSN: 08936692     EISSN: 10982280     Source Type: Journal    
DOI: 10.1002/em.21720     Document Type: Letter

References (17)

1. Adams WT, Skopek TR. 1987. Statistical test for the comparison of samples from mutational spectra. J Mol Biol 194: 391-396.
2. Benigni R, Palombo F, Dogliotti E. 1992. Multivariate statistical analysis of mutational spectra of alkylating agents. Mutat Res 267: 77-88.
3. Cooper DN, Krawczak M. 1990. The mutational spectrum of single base-pair substitutions causing human genetic disease: Patterns and predictions. Hum Genet 85: 55-74.
4. Hill KA, Buettner VL, Glickman BW, Sommer SS. 1999. Spontaneous mutations in the Big Blue transgenic system are primarily mouse derived. Mutat Res 436: 11-19.
5. Jackson AL, Loeb LA. 2001. The contribution of endogenous sources of DNA damage to the multiple mutations in cancer. Mutat Res 477: 7-21.
6. Lambert IB, Singer TM, Boucher SE, Douglas GR. 2005. Detailed review of transgenic rodent mutation assays. Mutat Res 590: 1-280.
7. Leavitt SA, George MH, Moore T, Ross JA. 2008. Mutations induced by benzo[a]pyrene and dibenzo[a, l]pyrene in lacI transgenic B6C3F1 mouse lung result from stable DNA adducts. Mutagenesis 23: 445-450.
8. Lewis PD, Manshian B, Routledge MN, Scott GB, Burns PA. 2008. Comparison of induced and cancer-associated mutational spectra using multivariate data analysis. Carcinogenesis 29: 772-778.
9. OECD. 2011. Test No. 488: Transgenic Rodent Somatic and Germ Cell Gene Mutation Assays. OECD Publishing, Paris.
10. Ross JA, Leavitt SA. 1998. Induction of mutations by 2-acetylaminofluorene in lacI transgenic B6C3F1 mouse liver. Mutagenesis 13: 173-179.
11. Ross JA, Leavitt SA. 2010. Analysis of the mutations induced by conazole fungicides in vivo. Mutagenesis 25: 231-234.
12. Ross JA, Moore T, Leavitt SA. 2009. In vivo mutagenicity of conazole fungicides correlates with tumorigenicity. Mutagenesis 24: 149-152.
13. Ross JA, Leavitt SA, Schmid JE, Nelson GB. 2012. Quantitative changes in endogenous DNA adducts correlate with conazole in vivo mutagenicity and tumorigenicity. Mutagenesis (Epub ahead of print, doi: 10.1093/mutage/ges017/.
14. Shane BS, Lockhart AM, Winston GW, Tindall KR. 1997. Mutant frequency of lacI in transgenic mice following benzo[a]pyrene treatment and partial hepatectomy. Mutat Res 377: 1-11.
15. Shane BS, Zeiger E, Piegorsch WW, Booth ED, Goodman JI, Peffer RC. 2012. Re-evaluation of the Big Blue® mouse assay of propiconazole suggests lack of mutagenicity. Environ Mol Mutagen 53: 1-9.
16. Skopek TR, Marino DR, Kort KL, Miller J, Pippert T. 1996. Synthesis of a lacI gene analogue with reduced CpG content. Mutat Res 349: 163-172.
17. Skopek TR, Marino D, Kort K, Miller J, Trumbauer M, Gopal S, Chen H. 1998. Effect of target gene CpG content on spontaneous mutation in299 transgenic mice. Mutat Res 400: 77-88.